Nanjing Pharmaceutical Group Company Limited (SHA:600713)
4.930
-0.040 (-0.80%)
May 28, 2026, 3:00 PM CST
-2.76% (1Y)
| Market Cap | 6.45B -1.4% |
| Revenue (ttm) | 54.56B +1.1% |
| Net Income | 622.04M +5.6% |
| EPS | 0.41 -8.0% |
| Shares Out | 1.31B |
| PE Ratio | 11.90 |
| Forward PE | n/a |
| Dividend | 0.17 (3.42%) |
| Ex-Dividend Date | Jun 30, 2025 |
| Volume | 7,936,500 |
| Open | 4.950 |
| Previous Close | 4.970 |
| Day's Range | 4.880 - 4.990 |
| 52-Week Range | 4.810 - 6.650 |
| Beta | 0.31 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 28, 2026 |